Obstructive Sleep Apnea: Clinical Trials

36 trials for Obstructive Sleep Apnea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed. 36 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 436Completed 36

Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA
Dexmedetomidine-esketamine combination, Placebo - Obstructive Sleep Apnea, Surgery
Phase 4CompletedPeking University First Hospital1002024-09-112026-09-04
Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA
Eszopiclone 3 mg, Placebo - Obstructive Sleep Apnea, Insomnia
Phase 4CompletedUniversity of Sao Paulo General Hospital602023-08-242026-05-29
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Sugammadex 100 MG/ML [Bridion] - Respiratory Complication, Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, Los Angeles122482022-02-182025-07-29
Ketorolac on Postoperative Pain Reduction in Pediatric Patients with Adenotonsillectomy
Ketorolac - Adenotonsillar Hypertrophy, Obstructive Sleep Apnea
Phase 4CompletedSt. Louis University1422022-02-082025-02-03
First Line Obstructive Sleep Apnea Treatment Study
Mandibular advancement device (MAD), Continuous positive airway pressure (CPAP) - Obstructive Sleep Apnea
Phase 4CompletedUniversity Hospital, Antwerp1362021-11-092025-02-14
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
Solriamfetol, Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea
Phase 4CompletedAxsome Therapeutics, Inc.592021-05-172026-01-26
Optimal Dosage of Acetazolamide for OSA Treatment
Acetazolamide, Placebo - Obstructive Sleep Apnea
Phase 4CompletedUniversity Hospital, Antwerp912021-04-202025-09-24
Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea
Dexmedetomidine, Placebo - Obstructive Sleep Apnea, Analgesia
Phase 4CompletedPeking University First Hospital1522021-01-292022-12-13
Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
Tolterodine Tartrate 4 MG, Continuous positive airway pressure therapy (CPAP) - Overactive Bladder, Obstructive Sleep Apnea
Phase 4CompletedYuzuncu Yil University602020-06-012022-02-22
Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
Sugammadex Sodium, Neostigmine - Obstructive Sleep Apnea
Phase 4CompletedUniversity Health Network, Toronto1202019-01-142025-03-20
Effect of Ketorolac on Post Adenotonsillectomy Pain
Ketorolac, Standard of Care - Obstructive Sleep Apnea
Phase 4CompletedEmory University632018-07-192024-09-19
Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
Sinemet CR, Placebo oral capsule - Parkinson's Disease, Obstructive Sleep Apnea
Phase 4CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre362017-05-242024-03-13
The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
Venlafaxine, Placebo - Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, San Diego202016-03-012020-04-17
Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic
Guanfacine, Hydrochlorothiazide - Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, San Diego412015-01-012020-12-04
The Impact of Arousal Threshold in Obstructive Sleep Apnea
Donepezil, placebo - Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, San Diego442014-09-012019-08-08
Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
Eplerenone 50 mg Tab - Hypertension,Essential, Obstructive Sleep Apnea
Phase 4CompletedPoznan University of Medical Sciences1252014-07-012017-06-14
Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study
Inspire® Upper Airway Stimulation (UAS) System - Obstructive Sleep Apnea
Phase 4CompletedInspire Medical Systems, Inc.602014-06-012020-07-02
Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea
Lasilactone, Sodium-Restricted Diet, Placebo - Obstructive Sleep Apnea
Phase 4CompletedHospital de Clinicas de Porto Alegre542013-10-012015-08-20
A Comparison of Surgical Outcome Following Drug-induced Sleep Endoscopic Diagnosis Using Propofol or Dexmedetomidine for Sedation : A Prospective Randomized Trial
Propofol, propofol-remifentanil, Dexmedetomidine-remifentanil - Obstructive Sleep Apnea
Phase 4CompletedYonsei University602012-07-012016-08-17
Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Sugammadex, Neostigmine - Obstructive Sleep Apnea
Phase 4CompletedDiskapi Teaching and Research Hospital742012-01-012014-12-09

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Sleep Apnea, Obstructive (36)  ·  Sleep Apnea Syndromes (6)  ·  Disorders of Excessive Somnolence (4)  ·  Hypertension (3)  ·  Pain, Postoperative (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Sleep Wake Disorders (2)  ·  Acidosis (1)  ·  Agnosia (1)  ·  Apnea (1)  ·  Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Depressive Disorder, Major (1)  ·  Dysthymic Disorder (1)  ·  Essential Hypertension (1)

Broader conditions

Dyssomnias (36)  ·  Nervous System Diseases (36)  ·  Respiration Disorders (36)  ·  Respiratory Tract Diseases (36)  ·  Sleep Disorders, Intrinsic (36)  ·  Apnea (35)  ·  Sleep Wake Disorders (34)  ·  Sleep Apnea Syndromes (30)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Signs and Symptoms (9)  ·  Mental Disorders (8)  ·  Cardiovascular Diseases (7)  ·  Vascular Diseases (7)  ·  Neurologic Manifestations (6)  ·  Pathologic Processes (4)

Interventions

Continuous Positive Airway Pressure (5)  ·  Eszopiclone (3)  ·  Sugammadex (3)  ·  Dexmedetomidine (2)  ·  Ketorolac (2)  ·  Neostigmine (2)  ·  Propofol (2)  ·  Acetazolamide (1)  ·  Budesonide (1)  ·  Calcium Dobesilate (1)  ·  Diet, Sodium-Restricted (1)  ·  Donepezil (1)  ·  Drug Delivery Systems (1)  ·  Eplerenone (1)  ·  Furosemide (1)

Sponsors

University of California, San Diego (3)  ·  Peking University First Hospital (2)  ·  Regional Hospital Holstebro (2)  ·  University Hospital, Antwerp (2)  ·  University of Cincinnati (2)  ·  University of Sao Paulo (2)  ·  Walter Reed Army Medical Center (2)  ·  Associação Fundo de Incentivo à Pesquisa (1)  ·  Axsome Therapeutics, Inc. (1)  ·  Cephalon (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Emory University (1)  ·  Hospital de Clinicas de Porto Alegre (1)  ·  Inspire Medical Systems, Inc. (1)  ·  Laval University (1)

Countries

United States (13)  ·  Brazil (5)  ·  Canada (3)  ·  Belgium (2)  ·  China (2)  ·  Denmark (2)  ·  Turkey (Türkiye) (2)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Christopher J Lettieri, MD (2)  ·  David L Steward, MD (2)  ·  Erling B Pedersen, Professor (2)  ·  Andrzej Tykarski, Prof (1)  ·  Armin Steffen, PD Dr. med. (1)  ·  Clemens Heiser, Dr. med. (1)  ·  Daniela K. Andaku, MSc (1)  ·  Denis Martinez, MD, PhD (1)  ·  Dong-Xin Wang, M.D. (1)  ·  Dong-Xin Wang, MD, PhD (1)  ·  Jean Wong, MD (1)  ·  Joachim T. Maurer, OA Dr. med. (1)  ·  Laura Gilbertson, MD (1)

Results publications

PMID 10450601, PMID 10678860, PMID 10908222, PMID 10940788, PMID 11208620, PMID 11422885, PMID 16376782, PMID 17494787, PMID 17556718, PMID 17921053, PMID 1798888, PMID 18404673, PMID 18458174, PMID 18595959, PMID 18663661, PMID 18788656, PMID 19357147, PMID 19567493, PMID 19920270, PMID 20016520, PMID 20051221, PMID 20411620, PMID 20522795, PMID 20642206, PMID 23952854, PMID 24107724, PMID 25325463, PMID 25547036, PMID 25906818, PMID 26208670, PMID 26914592, PMID 2698218, PMID 27442715, PMID 28105667, PMID 28296427, PMID 28408103, PMID 28567688, PMID 29029237, PMID 29217597, PMID 29243273, PMID 2936235, PMID 29669139, PMID 30130421, PMID 30324547, PMID 30794310, PMID 31538602, PMID 32278781, PMID 33333899, PMID 33341644, PMID 34156917